不同剂量枯草杆菌二联活菌颗粒治疗轮状病毒性肠炎效果评价
Evaluation of Effect of the Treatment to Rotavirus Enteritis with Different Dose Medilac-Vita

作者: 吴启富 :四川省华蓥市妇幼保健院儿科,华蓥;

关键词: 枯草杆菌二联活菌颗粒轮状病毒性肠炎Medilac-Vita Rotavirus Enteritis

摘要:
目的:评估不同剂量枯草杆菌二联活菌颗粒治疗轮状病毒性肠炎的临床效果。方法:选择240例轮状病毒性肠炎患儿随机分成大剂量组(120例)和小剂量组(120例)。两组予补液,口服消旋卡多曲颗粒。小剂量组加服枯草杆菌二联活菌颗粒<1岁,每次0.5 g,1~2岁每次1 g,2次/d;大剂量组加服枯草杆菌二联活菌颗粒<1岁,每次1 g,1~2岁每次2 g,2次/d。疗程3~7 d。比较两组临床效果。结果:大剂量组和小剂量组临床显效率(79.17% vs 60.00%)、总有效率(99.17% vs 89.17%)比较差异有统计学意义;治疗3 d后日均大便分别(1.31 ± 0.66)次、(1.62 ± 0.88)次(t = 3.087, P = 0.002),腹泻平均持续时间分别(2.89 ± 1.16) d、(3.43 ± 1.14) d (t = 3.637, P= 0.000)。结论:大剂量枯草杆菌二联活菌颗粒治疗轮状病毒性肠炎可显著提高疗效,减少大便次数,缩短腹泻持续时间,具有较高的临床应用价值。

Abstract: Objective: To evaluate the efficacy of different dose medilac-vita in treatment of children with ro-tavirus enteritis. Methods: 240 cases were randomly divided into low dose group with 120 cases and high dose group with 120 cases. Both groups were treated with complement fluid, racecadotril and different dose medilac-vita (low dose group: under 1 year old 0.5 g, 1 - 2 years old 1 g, 2 times a day; high dose group: under 1 year old 1 g, 1 - 2 years old 2 g, 2 times a day). All the treatments lasted for 3 - 7 days. The clinical efficacy of both groups was observed. Results: The high dose group’s total effective rate was 99.17% and control group’s was 89.17%. And there was also a statistic difference in curative rate (79.17% vs 60.00%). On the 4th day, the patients in the high dose group passed (1.31 ± 0.66) stools/day versus (1.62 ± 0.88) stools/day in the low dose group (t = 3.087, P = 0. 002). The mean diarrhea duration was (2.89 ± 1.16) days in the high dose group and (3.43 ± 1.14) days in the low dose group (t = 3.637, P = 0.000). Conclusions: The high dose me-dilac-vita can improve the remarkable effective rate in children with rotavirus enteritis, reduce stool frequency and decrease the duration of diarrhea; it is worthy of application.

文章引用: 吴启富 (2014) 不同剂量枯草杆菌二联活菌颗粒治疗轮状病毒性肠炎效果评价。 临床个性化医学, 2, 1-5. doi: 10.12677/JCPM.2014.21001

参考文献

[1] 王文建 (2010) 国内儿科微生态制剂的临床应用. 中国实用儿科杂志, 25, 557-559.

[2] 郑跃杰, 黄志华, 刘作义等 (2011) 微生态制剂儿科应用专家共识(2010年10月). 中国实用儿科杂志, 26, 20-23.

[3] 郭彤, 蒋红英 (2009) 妈咪爱联合利巴韦林、思密达治疗婴幼儿轮状病毒肠炎的观察. 中国微生态学杂志, 21, 545-546.

[4] 方鹤松, 魏承毓, 段恕诚等 (1998) 中国腹泻病诊断治疗方案. 中国实用儿科杂志, 13, 381-384.

[5] 李朝平, 张解军 (2009) 止泻保童颗粒佐治小儿急性腹泻病的疗效观察. 儿科药学杂志, 15, 31-33.

[6] 何念海, 赵文利 (2010) 中国儿童感染性腹泻诊治进展. 实用儿科临床杂志, 25, 1694-1696.

[7] 欧亚娟, 刘雪琴 (2010) 酪酸梭菌、婴儿型双歧杆菌二联活菌治疗小儿急性腹泻病的临床观察. 儿科药学杂志, 16, 23-24.

[8] 林谦, 金玉, 周进苏等 (2012) 2009至2010年南京儿童医院5岁以下儿童病毒性腹泻分子流行病学特点. 中国循证儿科杂志, 7, 31-36.

[9] 邓莉, 贾立英, 赵惠欣等 (2007) 婴幼儿轮状病毒性肠炎140例发病特点分析. 临床儿科杂志, 25, 295-297.

[10] 赵红立, 秦立波 (2011) 酪酸梭菌活菌散与蒙托石散间隔联用治疗婴幼儿病毒性腹泻疗效观察. 中国微生态学杂志, 23, 60-63.

[11] 郑跃杰, 黄志华 (2011) 正确认识评价和使用益生菌药物. 中国实用儿科杂志, 26, 24-26.

[12] 武庆斌 (2010) 微生态制剂在小儿腹泻病中的应用. 实用儿科临床杂志, 25, 1458-1460.

[13] 肖国光, 万朝敏 (2010) 微生态制剂防治儿童腹泻病的研究证据及评价. 中国实用儿科杂志, 25, 512-515.

[14] 顾蓁, 沈华琴, 赵普 (2011) 锌制剂防治小儿急性腹泻效果观察. 临床儿科杂志, 29, 249-251.

分享
Top